Validation of Sputum Biomarker Immunoassays and Cytokine Expression Profiles in COPD.

airway colonisation biomarker chronic obstructive pulmonary disease inflammatory endotype sputum validation

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
11 Aug 2022
Historique:
received: 30 05 2022
revised: 02 08 2022
accepted: 08 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 27 8 2022
Statut: epublish

Résumé

Immunoassays are commonly used to assess airway inflammation in sputum samples from chronic obstructive pulmonary disease (COPD) patients. However, assay performance and validation in this complex matrix is inconsistently reported. The aim of this study was to assess the suitability of various immunoassays for use with sputum samples, followed by use of validated immunoassays to evaluate biomarker levels in COPD patients. Assays were assessed for recombinant reference standard suitability, optimal sample dilution, standard recovery in the biological matrix and reproducibility. Validated assays were used to assess sputum supernatants in Cohort A (

Identifiants

pubmed: 36009496
pii: biomedicines10081949
doi: 10.3390/biomedicines10081949
pmc: PMC9405928
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : AstraZeneca (USA)
ID : Not Applicable

Références

Thorax. 2012 Dec;67(12):1075-80
pubmed: 22863758
Thorax. 2014 Sep;69(9):857-64
pubmed: 24781218
Clin Chem Lab Med. 2007;45(1):108-11
pubmed: 17243926
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
N Engl J Med. 2004 Jun 24;350(26):2645-53
pubmed: 15215480
Am J Respir Crit Care Med. 2011 Sep 15;184(6):662-71
pubmed: 21680942
Respir Res. 2010 Apr 22;11:41
pubmed: 20412595
Eur Respir J. 2021 Oct 14;58(4):
pubmed: 33766947
PLoS One. 2012;7(10):e46207
pubmed: 23056262
Respiration. 2012;83(1):36-44
pubmed: 21912093
AAPS J. 2007 Jun 29;9(2):E260-7
pubmed: 17907767
Cytokine. 2015 Feb;71(2):401-4
pubmed: 25464927
Respir Res. 2020 Nov 1;21(1):289
pubmed: 33131502
J Pharm Biomed Anal. 2011 Jul 15;55(5):869-77
pubmed: 21530130
BMC Immunol. 2020 Oct 1;21(1):52
pubmed: 32998687
Eur Respir J. 2022 May 26;59(5):
pubmed: 35210322
Cytokine. 2010 May;50(2):152-7
pubmed: 20181491
Bone Marrow Transplant. 2014 Nov;49(11):1382-8
pubmed: 25068427
Am J Respir Crit Care Med. 2016 Sep 1;194(5):541-9
pubmed: 27585383
Am J Respir Crit Care Med. 2001 Feb;163(2):349-55
pubmed: 11179105
Int J Chron Obstruct Pulmon Dis. 2015 Jun 09;10:1075-83
pubmed: 26089657
Bioanalysis. 2014 Jan;6(2):185-98
pubmed: 24423595
Am J Respir Crit Care Med. 2022 Jul 1;206(1):17-24
pubmed: 35737975
Respiration. 2009;78(3):256-62
pubmed: 19478474
Am J Physiol Lung Cell Mol Physiol. 2009 May;296(5):L839-48
pubmed: 19286926
Bioanalysis. 2012 Oct;4(20):2439-46
pubmed: 23157353
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1488-1502
pubmed: 33332995
Bioanalysis. 2017 Jul;9(14):1107-1122
pubmed: 28737442
Am Rev Respir Dis. 1992 Jun;145(6):1321-7
pubmed: 1595997
AAPS J. 2016 Nov;18(6):1366-1372
pubmed: 27514862
AAPS J. 2016 Jan;18(1):1-14
pubmed: 26377333
Biomedicines. 2021 Sep 27;9(10):
pubmed: 34680454
Bioanalysis. 2016 Feb;8(3):163-7
pubmed: 26795584
Thorax. 2002 Aug;57(8):667-71
pubmed: 12149524
Pharm Res. 2006 Feb;23(2):312-28
pubmed: 16397743
Eur Respir J. 2000 Apr;15(4):778-81
pubmed: 10780773
J Allergy Clin Immunol. 2004 Apr;113(4):657-62
pubmed: 15100669
ERJ Open Res. 2016 Oct 26;2(4):
pubmed: 28053970
Cytokine. 2008 May;42(2):205-216
pubmed: 18358739
Am J Respir Crit Care Med. 2006 Jul 1;174(1):6-14
pubmed: 16556692
Am J Respir Crit Care Med. 2019 May 15;199(10):1195-1204
pubmed: 30592902
Curr Opin HIV AIDS. 2010 Nov;5(6):463-6
pubmed: 20978388
Allergy. 2020 Apr;75(4):808-817
pubmed: 31556120
Eur Respir J Suppl. 2002 Sep;37:24s-39s
pubmed: 12361360
J Allergy Clin Immunol. 2000 Aug;106(2):280-7
pubmed: 10932071
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151

Auteurs

Alex Mulvanny (A)

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester M13 9PL, UK.
Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester M23 9QZ, UK.

Caroline Pattwell (C)

Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester M23 9QZ, UK.

Augusta Beech (A)

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester M13 9PL, UK.

Thomas Southworth (T)

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester M13 9PL, UK.
Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester M23 9QZ, UK.

Dave Singh (D)

Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester M13 9PL, UK.
Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester M23 9QZ, UK.

Classifications MeSH